355 articles
Lewis C. Cantley
Lewis C. Cantley, born 1949, is an American biochemist known for discovering PI3K, a signaling enzyme central to cancer and diabetes, and for cancer metabolism research.
Lisa Licitra
Lisa Licitra is an Italian medical oncologist who heads head and neck cancer medical oncology at Milan's Istituto Nazionale dei Tumori and led the BERIL-1 trial.
Lisa M. DeAngelis
Lisa M. DeAngelis is an American neuro-oncologist who spent nearly 40 years at Memorial Sloan Kettering, chairing its neurology department and co-founding its Brain Tumor Center.
Lori J. Wirth
Lori J. Wirth is an American medical oncologist who leads the Center for Head and Neck Cancers at Massachusetts General Hospital and specializes in thyroid cancer.
Luca Gianni
Luca Gianni, born in Milan in 1951, is an Italian medical oncologist whose NOAH and NeoSphere trials established neoadjuvant and dual-blockade HER2 therapy in breast cancer.
Luis Paz‐Ares
Luis Paz-Ares is a Spanish medical oncologist specializing in thoracic cancers, who heads medical oncology at Hospital Universitario 12 de Octubre in Madrid and the joint H12O-CNIO lung cancer research unit.
Maha Hussain
Maha Hussain is an Iraqi-born American medical oncologist specializing in prostate and bladder cancer who leads genitourinary oncology at Northwestern University and led the PROSPER and PROfound prostate cancer trials.
Manuel Hidalgo (oncologist)
Manuel Hidalgo, full name Manuel Hidalgo Medina, is a Spanish-trained medical oncologist known for pancreatic cancer drug development, pioneering patient-derived xenograft "avatar" mouse models, and advancing nab-paclitaxel.
Marco Colleoni
Marco Colleoni is an Italian medical oncologist who directs the Division of Medical Senology at the European Institute of Oncology in Milan, specializing in breast cancer.
Margaret A. Shipp
Margaret A. Shipp is an American medical oncologist who leads the Division of Hematologic Neoplasia at Dana-Farber and coordinated the International Prognostic Index for lymphoma.
Marina Chiara Garassino
Marina Chiara Garassino is an Italian medical oncologist specializing in thoracic cancers, and Professor of Medicine and Director of Thoracic Programs at the University of Chicago, known for leading the KEYNOTE-189 trial.
Mario A. Eisenberger
Mario A. Eisenberger is a medical oncologist and Professor Emeritus at Johns Hopkins whose TAX 327 docetaxel trial established chemotherapy as survival-prolonging treatment for metastatic prostate cancer.
Mark A. Socinski
Mark A. Socinski is an American medical oncologist specializing in lung cancer and mesothelioma, and Executive Medical Director of the AdventHealth Cancer Institute in Orlando, Florida.
Mark Bower
Mark Bower is a British medical oncologist, Professor at Imperial College London and consultant at Chelsea and Westminster Hospital, known for AIDS-related cancer care and a 2006 Kaposi's sarcoma prognostic index.
Mark G. Kris
Mark G. Kris is an American thoracic medical oncologist and emeritus member of Memorial Sloan Kettering, known for clinical trials bringing EGFR-targeted therapy into lung cancer practice.
Mark J. Ratain
Mark J. Ratain, born 1954, is an American oncologist at the University of Chicago known for cancer pharmacogenetics, phase I trial design, and the UGT1A1 work behind the 2005 irinotecan label change.
Mark N. Levine
Mark N. Levine is a Canadian medical oncologist and Professor Emeritus at McMaster University whose trials shortened chemotherapy after breast cancer surgery and reshaped radiotherapy.
Markus Raderer
Markus Raderer is an Austrian oncologist and associate professor at the Medical University of Vienna, known for his research on MALT lymphoma and gastrointestinal tumors.
Marshall R. Posner
Marshall R. Posner is an American medical oncologist known for leading the phase 3 TAX 324 trial of TPF chemotherapy for head and neck cancer and rituximab therapy for pemphigus vulgaris.
Martin H.N. Tattersall
Martin H.N. Tattersall (1941–2020) was a British-born Australian medical oncologist, the first professor of cancer medicine in the southern hemisphere, at the University of Sydney from 1977.
Martin J. van den Bent
Martin J. van den Bent, also written Martin van den Bent, is a Dutch neurologist and neuro-oncologist who led the Neuro-Oncology Unit at Erasmus MC, Rotterdam, and led the CATNON glioma trial.
Martin Schlumberger
Martin Schlumberger is a French thyroid-cancer oncologist and nuclear medicine specialist who headed Gustave Roussy's nuclear medicine department from 1980 to 2019 and led the SELECT lenvatinib trial.
Martine Piccart
Martine Piccart is a Belgian medical oncologist, Scientific Director at the Institut Jules Bordet in Brussels, who led the HERA and MINDACT trials and co-founded the Breast International Group.
Matthew R. Smith
Matthew R. Smith, also published as Matthew Raymond Smith, is an American medical oncologist specializing in prostate cancer who directs the Genitourinary Malignancies Program at Mass General Cancer Center.
Matthias Preusser
Matthias Preusser is an Austrian medical oncologist and neuro-oncologist, head of oncology at the Medical University of Vienna since 2018 and a past president of EANO.
Michael A. Caligiuri
Michael A. Caligiuri is an American medical oncologist known for research on interleukin-15 and natural killer cells, and a professor at City of Hope since 2023.
Michael C. Heinrich
Michael C. Heinrich is an American medical oncologist and professor at the OHSU Knight Cancer Institute, known for identifying PDGFRA mutations in gastrointestinal stromal tumor and leading trials of tyrosine kinase inhibitors.
Michael J. Keating
Michael J. Keating is an Australian-born hematologist-oncologist who spent nearly five decades at MD Anderson Cancer Center, developing the FCR regimen that transformed chronic lymphocytic leukemia treatment.
Michael J. Seckl
Michael J. Seckl is a British medical oncologist, Professor of Molecular Oncology at Imperial College London, who directs the national Gestational Trophoblastic Disease Service and developed the TE/TP regimen.
Michael M. Gottesman
Michael M. Gottesman is an American physician-scientist at the National Cancer Institute whose laboratory showed that the P-glycoprotein pump drives multidrug resistance in cancer cells.